Table 2.

Crude outcomes of all patients who had pancreatic surgery for a malignancy or adenocarcinoma of the pancreas

	All pancreatic malignancies				Pancreatic adenocarcinomas
	1996–2000 N = 85	2001–2005 N = 89	2006–2008 N = 110	P value	1996–2000 N = 72	2001–2005 N = 71	2006–2008 N = 98	P value
30-day mortality	7 (8%)	0	2 (2%)	a	5 (7%)	0	2 (2%)	a
90-day survival	75 (88%)	86 (97%)	106 (96%)	.03	64 (89%)	68 (96%)	95 (96%)	.12
1-year survival	55 (65%)	58 (65%)	81 (74%)	.31	46 (64%)	40 (56%)	70 (71%)	.13
2-year survival	33 (39%)	36 (40%)	36 (55%)	.09	27 (38%)	20 (28%)	29 (49%)	.04
Lymph nodes (median)	2	4	7	<.001	2	4	7	<.001

^aNot feasible to calculate significance